Unicycive Therapeutics

Unicycive Therapeutics UNCY Stock

$3.73   0.810810%
Add to favorites
Market Cap
$108.86M
LOW - HIGH [24H]
$3.67 - $3.75
VOLUME [24H]
$187.70K
P/E Ratio
0
Earnings per share
-$1.64
ISIN
US90466Y2028
Price   Prediction

Unicycive Therapeutics Price Chart

Sorry, that's all we've gotfor now...

Unicycive Therapeutics (UNCY) stock price today is 3.73 USD on Tech Market Small (+0.81% on the day). Updated .

Unicycive Therapeutics UNCY Financial and Trading Overview

Unicycive Therapeutics stock price 3.73 USD
Previous Close 3.7 USD
Open 3.69 USD
Bid 3.6 USD x 200
Ask 3.78 USD x 100
Day's Range 3.59 - 3.77 USD
52 Week Range 3.33 - 8.74 USD
Volume 785.88K USD
Avg. Volume 940.21K USD
Market Cap 107.98M USD
Beta (5Y Monthly) 1.864
PE Ratio (TTM) N/A
EPS (TTM) -1.64 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 26.3 USD

UNCY Valuation Measures

Enterprise Value 49.53M USD
Trailing P/E N/A
Forward P/E 2.5517242
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.9351466
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.431

Trading Information

Unicycive Therapeutics Stock Price History

Beta (5Y Monthly) 1.864
52-Week Change -37.50%
S&P500 52-Week Change 12.07%
52 Week High 8.74 USD
52 Week Low 3.33 USD
50-Day Moving Average 4.17 USD
200-Day Moving Average 5.93 USD

UNCY Share Statistics

Avg. Volume (3 month) 940.21K USD
Avg. Daily Volume (10-Days) 844.92K USD
Shares Outstanding 29.18M
Float 28.51M
Short Ratio 4.45
% Held by Insiders 2.25%
% Held by Institutions 40.84%
Shares Short 4.82M
Short % of Float 17.69%
Short % of Shares Outstanding 17.29%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor 1:10

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -35.92%
Return on Equity (ttm) -80.37%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -34611000 USD
Net Income Avi to Common (ttm) -36211000 USD
Diluted EPS (ttm) -1.72
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 58.97M USD
Total Cash Per Share (mrq) 2.02 USD
Total Debt (mrq) 522K USD
Total Debt/Equity (mrq) 0.99 USD
Current Ratio (mrq) 3.996
Book Value Per Share (mrq) 1.912

Cash Flow Statement

Operating Cash Flow (ttm) -29126000 USD
Levered Free Cash Flow (ttm) -13736125 USD

Profile of Unicycive Therapeutics

Country United States
State CA
City Mountain View
Address 1975 West El Camino Real
ZIP 94040
Phone 650 351 4495
Website https://unicycive.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 21

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI-494, a nicotinamide ester derivative and a selective ATP-sensitive mitochondrial potassium channel activator, which is in Phase I clinical trial for the treatment of acute kidney injury and pre-clinical stage for the treatment of chronic kidney disease. The company was incorporated in 2016 and is headquartered in Mountain View, California.

Q&A For Unicycive Therapeutics Stock

What is a current UNCY stock price?

Unicycive Therapeutics UNCY stock price today per share is 3.73 USD.

How to purchase Unicycive Therapeutics stock?

You can buy UNCY shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Unicycive Therapeutics?

The stock symbol or ticker of Unicycive Therapeutics is UNCY.

Which industry does the Unicycive Therapeutics company belong to?

The Unicycive Therapeutics industry is Biotechnology.

How many shares does Unicycive Therapeutics have in circulation?

The max supply of Unicycive Therapeutics shares is 29.18M.

What is Unicycive Therapeutics Price to Earnings Ratio (PE Ratio)?

Unicycive Therapeutics PE Ratio is now.

What was Unicycive Therapeutics earnings per share over the trailing 12 months (TTM)?

Unicycive Therapeutics EPS is -1.64 USD over the trailing 12 months.

Which sector does the Unicycive Therapeutics company belong to?

The Unicycive Therapeutics sector is Healthcare.

Unicycive Therapeutics UNCY included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24462.84 USD —
+0.55
1.95B USD — 24268.03 USD — 24538.78 USD — — 1.95B USD —
us US Tech Health Care IXHC US 1340.2 USD —
+0.55
— — 1325.21 USD — 1342.46 USD — — — —
$2.18T
Total marketcap
$71.41B
Total volume
BTC 58.24%   •   ETH 9.87%
Dominance
Select currency